Kymera Therapeutics, Inc.
KYMR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815442
In the last 90 days, Kymera Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 276 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Kymera Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- −2 vs. Q4 2021
- Shares held
- 45.7M
- +2.21M (+5.1%) vs. Q4 2021
- Total value
- $1.93B
- −$825.8M (−29.9%) vs. Q4 2021
- New holders
- 17
- 60 more added
- Sold out
- 19
- 32 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 276 | $11.1B |
| Q1 2026 | 256 | $8.01B |
| Q4 2025 | 255 | $6.99B |
| Q3 2025 | 210 | $4.58B |
| Q2 2025 | 210 | $3.44B |
| Q1 2025 | 174 | $2.00B |
| Q4 2024 | 181 | $2.89B |
| Q3 2024 | 176 | $3.27B |
| Q2 2024 | 157 | $2.01B |
| Q1 2024 | 164 | $2.70B |
| Q4 2023 | 137 | $1.54B |
| Q3 2023 | 122 | $797.2M |
| Q2 2023 | 129 | $1.34B |
| Q1 2023 | 127 | $1.68B |
| Q4 2022 | 121 | $1.40B |
| Q3 2022 | 128 | $1.15B |
| Q2 2022 | 101 | $973.6M |
| Q1 2022 | 126 | $1.93B |
| Q4 2021 | 128 | $2.76B |
| Q3 2021 | 115 | $2.04B |
| Q2 2021 | 110 | $1.29B |
| Q1 2021 | 97 | $887.2M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Kymera Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dimensional Fund Advisors LP | 237,731 | $10.1M | 0.00% | +172,839+266.3% | Added |
| Goldman Sachs Group Inc | 243,926 | $10.3M | 0.00% | −23,864−8.9% | Reduced |
| Charles Schwab Investment Management Inc | 255,277 | $10.8M | 0.00% | +6,743+2.7% | Added |
| Northern Trust Corp | 319,870 | $13.5M | 0.00% | −19,030−5.6% | Reduced |
| Sphera Funds Management Ltd. | 368,061 | $15.6M | 2.61% | +49,394+15.5% | Added |
| Candriam Luxembourg S.C.A. | 414,713 | $17.6M | 0.12% | +11,894+3.0% | Added |
| UBS Asset Management Americas Inc | 430,243 | $18.2M | 0.01% | +164,192+61.7% | Added |
| AJU IB Investment Co., Ltd. | 457,059 | $19.3M | 29.87% | 00.0% | Unchanged |
| Deer Management Co. LLC | 615,895 | $26.1M | 0.90% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 623,770 | $26.4M | 0.00% | +3,728+0.6% | Added |
| Pictet Asset Management SA | 646,075 | $27.3M | 0.03% | +646,075 | New |
| Point72 Asset Management, L.P. | 652,800 | $27.6M | 0.12% | +594,600+1,021.6% | Added |
| Bank of New York Mellon Corp | 686,194 | $29.0M | 0.01% | +155,476+29.3% | Added |
| Rock Springs Capital Management LP | 755,875 | $32.0M | 0.81% | +13,810+1.9% | Added |
| Avoro Capital Advisors LLC | 816,500 | $34.6M | 0.63% | +266,500+48.5% | Added |
| Artal Group S.A. | 1,000,000 | $42.3M | 1.79% | 00.0% | Unchanged |
| FMR LLC | 1,923,889 | $81.4M | 0.01% | −423,638−18.0% | Reduced |
| State Street Corp | 2,094,561 | $88.6M | 0.00% | +452,799+27.6% | Added |
| Baker Bros. Advisors LP | 2,384,742 | $100.9M | 0.58% | 00.0% | Unchanged |
| Redmile Group, LLC | 2,615,030 | $110.7M | 3.45% | +27,300+1.1% | Added |
| Vanguard Group Inc | 2,837,725 | $120.1M | 0.00% | −119,449−4.0% | Reduced |
| Wellington Management Group LLP | 3,225,749 | $136.5M | 0.02% | +530,935+19.7% | Added |
| BlackRock Inc. | 3,419,084 | $144.7M | 0.00% | +21,544+0.6% | Added |
| BVF Inc | 3,586,658 | $151.8M | 6.07% | +406,000+12.8% | Added |
| Price T Rowe Associates Inc | 3,895,205 | $164.8M | 0.02% | +344,677+9.7% | Added |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $291.0M | 36.79% | 00.0% | Unchanged |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −670,000−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −182,326−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −155,000−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −93,049−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −48,987−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −29,695−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −28,989−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −26,791−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −10,454−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −5,607−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −4,960−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −4,206−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −3,256−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −1,238−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −21−100.0% | Sold out |